BiotechTube
Home/OMEICOS Therapeutics/Karen Uhlmann
KU

Karen Uhlmann

Vice President Operations & IP, Co-Founder

OMEICOS Therapeutics

Therapeutic Areas

CardiovascularInflammatory DiseasesMitochondrial Diseases

OMEICOS Therapeutics Pipeline

DrugIndicationPhase
OMT-28Atrial FibrillationPhase 2

Leadership Team at OMEICOS Therapeutics

RF
Robert Fischer
CEO, CSO, Co-Founder
SR
Simon Russell
CBO (Consultancy)
View full OMEICOS Therapeutics profile